Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women - Concepedia

Concepedia

Publication | Open Access

Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women

DOI Full Paper Access

43

Citations

16

References

2016

Year

Barbara Schütt, Andreas Kaiser, Marcus‐Hillert Schultze‐Mosgau, Christian Seitz, David Bell, Manuela C. Koch, Beate Rohde

Human Reproduction

Abstract

28 November 2011.

References

	Year	Citations

Page 1